Contact Us | 1-888-607-9692
Benjamin Charvet, PhD |
|||||
Benjamin is the Project Manager for the preclinical research lead by Geneuro company. Geneuro develops therapeutic antibodies directed against the Endogenous Retroviruses (HERVs), which are shown to be involved in various autoimmune disease and more recently in COVID-19. Benjamin’s PhD and his first post-doctorate focus was on muscle/tendon development and repair. During his second post-doctorate, Benjamin moved to the field of virology and began working on the HHV-6 virus and HERV-W interaction in multiple sclerosis in collaboration with Geneuro, whom he has been employed with since 2016. |
© 2021 Bio-Techne. All rights reserved.
Terms and conditions of Sale | Privacy Policy | Email Preferences